Dräger Desiree L, Heuschkel Martin, Protzel Chris, Erbersdobler Andreas, Krause Bernd J, Hakenberg Oliver W, Schwarzenböck Sarah M
Nuklearmedizin. 2018 Feb;57(1):26-30. doi: 10.3412/Nukmed-0932-17-10. Epub 2018 Feb 21.
Accurate staging of penile cancer requires invasive methods such as sentinel node biopsy or lymphadenectomy (LAD). We assessed the value of [F]FDG PET/CT for non-invasive nodal staging in penile cancer (PC) patients before inguinal LAD.
41 consecutive patients with PC (stage pT1 or higher, cN0) received [F]FDG PET/CT before undergoing bilateral modified or radical inguinal staging LAD. Lymph nodes with a visually increased [F]FDG uptake were classified as suspicious of lymph node metastases (LNM). Standardized uptake value (SUV) of suspicious inguinal lymph nodes was determined. Results of [F]FDG PET/CT were correlated with histopathology.
In total 623 lymph nodes were resected, in 10 patients LNM were histologically confirmed (14/623 lymph nodes). In patient-based analysis [F]FDG PET/CT showed a sensitivity and specificity of 80% and 68 %, respectively, a positive predictive value (PPV) of 44 % and a negative predictive value (NPV) of 91 %. In the groin-based analysis, [F]FDG PET/CT had a sensitivity of 69 %, a specificity of 77 %, a PPV of 36 % and a NPV of 93 %. There was no significant difference in SUV and SUV between true positive and false positive lymph nodes (p = 0.093 and 0.069, respectively).
[F]FDG PET/ CT shows a high NPV in penile cancer patients without clinically evident LNM. However, due to its limited sensitivity (especially with respect to LNM of small size) and specificity (i. e. in the differentiation between (post)inflammatory and metastatic lymph nodes) [F]FDG PET/CT cannot replace invasive nodal staging.
阴茎癌的准确分期需要采用侵入性方法,如前哨淋巴结活检或淋巴结清扫术(LAD)。我们评估了[F]FDG PET/CT在阴茎癌(PC)患者腹股沟LAD术前进行非侵入性淋巴结分期中的价值。
41例连续的PC患者(pT1期或更高分期,cN0)在接受双侧改良或根治性腹股沟分期LAD之前接受了[F]FDG PET/CT检查。[F]FDG摄取在视觉上增加的淋巴结被分类为可疑淋巴结转移(LNM)。测定可疑腹股沟淋巴结的标准化摄取值(SUV)。[F]FDG PET/CT的结果与组织病理学结果相关。
共切除623个淋巴结,10例患者经组织学证实有LNM(14/623个淋巴结)。在基于患者的分析中,[F]FDG PET/CT的敏感性和特异性分别为80%和68%,阳性预测值(PPV)为44%,阴性预测值(NPV)为91%。在基于腹股沟的分析中,[F]FDG PET/CT的敏感性为69%,特异性为77%,PPV为36%,NPV为93%。真阳性和假阳性淋巴结之间的SUV和SUVmax无显著差异(分别为p = 0.093和p = 0.069)。
[F]FDG PET/CT在无临床明显LNM的阴茎癌患者中显示出较高的NPV。然而,由于其敏感性有限(尤其是对于小尺寸LNM)和特异性(即区分(后)炎性和转移性淋巴结),[F]FDG PET/CT不能替代侵入性淋巴结分期。